CALGARY, ALBERTA--(Marketwired - Jan. 4, 2016) - QuikFlo Health Inc. ("QuikFlo" or the "Company") (TSX VENTURE:QF)(FRANKFURT:1QF) is pleased to announce our year end shareholder letter.
To our Shareholders,
For QuikFlo, 2015 was a seminal year. Early in the year, QuikFlo was only an idea, born and given life by our founding team's desire to improve stroke outcomes worldwide. As we close out 2015, QuikFlo is a public company with meaningful accomplishments behind it in every dimension critical to our success: fundraising, product development, recruiting, corporate governance, and honing our vision for the company.
I joined the company in mid-September, and in just the last three months, our team has:
- Closed our first financing round of $500,000
- Hired our first three full-time staff members
- Filed our first patent application
- Brought on Dr. Nils Forkert as our Head of Research
- Published groundbreaking research featured on the cover of the journal Stroke
- Been recognized for one of the top 5 publications of 2015 by the journal Radiology
- Submitted grant applications for potentially millions of dollars in non-dilutive funding
- Became actively traded on the TSX Venture Exchange under the symbol QF
Our high level of productivity results from a team that is extraordinarily talented, and driven by a compelling need to help the millions of people affected by stroke every year. Through the course of the coming year, we will continue to publish more thought-leading research, bolster our patent portfolio, add more exceptional people to our team, and convince more investors of the inevitability of our success. Moreover, we will continue realizing our product vision for FAST - Fast, Accurate Stroke Triage - to satisfy the market's need to improve stroke outcomes through better and faster decision-making.
Why build software to improve stroke triage? The answer is simple: short of a miracle drug, fixing the inefficient stroke triage process is the best way to improve stroke outcomes across the globe. Time is brain saved, and when triage and treatment decisions are delayed, patients suffer. QuikFlo codifies our founders' expertise into a software product that can guide physicians - anywhere in the world, and at any time of day - towards the right triage decision quickly. Patients are better served, hospitals run more efficiently and profitably, and the burden of stroke on society lessens.
We believe that a fundamentally important measure of our success is the shareholder value we create over the long-term. Stroke triage improvement represents an emerging market that will grow exponentially as the incidence of stroke, which is expected to double over the next 20 years, forces more hospitals to invest in solutions that produce better outcomes for patients and better economics for themselves. Because of our team and our vision for serving this market, QuikFlo is well-positioned to establish a leadership position as the potential of this market becomes reality. If we execute well, this is a position we can maintain for decades to come.
As always, my virtual door is open to you to hear your ideas, thoughts, and concerns. I look forward to corresponding with you, and communicating QuikFlo's progress to you in the coming year.
President and CEO